Yissum Technology Transfer Company of the Hebrew University
Yissum is the technology transfer company of the Hebrew University of Jerusalem, founded in 1964. It commercializes university research through IP licensing, sponsored research agreements, affiliated venture funds, and spin-off company creation across pharmaceuticals, AgTech, FoodTech, and technology sectors globally.
- Company typePrivate
- Founded1964
- HeadquartersJerusalem, Israel
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Yissum Technology Transfer Company of the Hebrew University does
Yissum Technology Transfer Company of the Hebrew University is the designated technology transfer office for The Hebrew University of Jerusalem, founded in 1964 as the third technology transfer company in the world. The company manages and commercializes all intellectual property generated at the university, currently overseeing 10,500+ patents, 2,500 inventions, 222 licensable technologies across 13 categories, and a portfolio of 112 spin-off companies. Its core function is to bridge academic research with global commercial markets through four partnership models: direct technology licensing, sponsored research agreements, the Enterprise Directed Research (EDGES) program, and spin-off company creation.
The company's product surface is not a single unified platform but rather an IP management and commercialization ecosystem spanning pharmaceuticals (88 technologies), AgTech (40), FoodTech & Nutrition (23), Computer Science & Engineering (23), diagnostics (20), medical devices (20), chemistry & nanotechnology (32), quantum (5), and several other categories. Notable specific technologies include an AI-Powered Discovery Platform for next-generation sweeteners, the PheLiz antimicrobial peptide platform for combating antimicrobial resistance, and the NKp46-Directed ADC Platform for T-cell lymphomas. Yissum operates affiliated venture funds (Integra for healthcare, Racah Nano Fund for nanotechnology) with first-look rights on Hebrew University innovations, and has additional revenue lines including the EduCann medical cannabis educational platform and the 'Out of the Lab' podcast.
Revenue is generated through licensing royalties, sponsored research fees, returns from affiliated venture funds, and equity participation in spin-off companies. The company is headquartered at the Edmond J. Safra Campus in Givat-Ram, Jerusalem, employs 11-50 staff, and serves a globally distributed base of industry partners including Pfizer, Merck, IBM Research, ICL, Mobileye/Intel, Clearmind Medicine, Fresh-Start FoodTech Incubator, and NetZero Tech Ventures. Notable historical exits include Mobileye (acquired by Intel for $15.3B), Doxil (the first FDA-approved nano-drug, 1995), and Exelon/Novartis (Alzheimer's treatment). Leadership includes CEO Alon Natanson (or Itzik Goldwaser per alternative sources), CFO/COO Sharon Cohen, and a board chaired by Barak Ben Eliezer with representation from Hebrew University leadership and external investors.
Yissum Technology Transfer Company of the Hebrew University firmographics
Firmographics- Name
- Yissum Technology Transfer Company of the Hebrew University
- Legal name
- Yissum Research Development Company of The Hebrew University of Jerusalem
- Website
- https://yissum.co.il
- Company type
- Private
- Founded year
- 1964
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Yissum is the technology transfer company of the Hebrew University of Jerusalem, founded in 1964. It commercializes university research through IP licensing, sponsored research agreements, affiliated venture funds, and spin-off company creation across pharmaceuticals, AgTech, FoodTech, and technology sectors globally.
- Ownership category
- akta.pro rank
Yissum Technology Transfer Company of the Hebrew University industry classification
Industry- Product category
- Technology Transfer & Intellectual Property Commercialization
- NAICS
- Lessors of Nonfinancial Intangible Assets (except Copyrighted Works) (533), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in Nanotechnology (541713)
- SIC
- Patent Owners & Lessors (6794), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- IP Licensing, Transactions & Technology Transfer (BPAHAMAF)
- akta.pro secondary industries
- Technology Transfer & Innovation-Driven Research Universities (High Commercialization) (EDAHABAH), IP Management, Patents & Trademark Software (BPAEAPAN)
Keywords
Where Yissum Technology Transfer Company of the Hebrew University is headquartered
LocationHeadquarters
- HQ city
- Jerusalem
- HQ country
- Israel
- HQ region
- Middle East
Offices1 record
Markets served
Yissum Technology Transfer Company of the Hebrew University business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Licensing Royalties: Revenue generated from licensing patented technologies and know-how to industry partners. Licenses granted under a variety of terms to suit business needs of industry partners, including exclusive and non-exclusive arrangements.
- Sponsored Research Agreements: Revenue from industry-sponsored research projects where Yissum facilitates partnership between Hebrew University researchers and industry partners to advance early-stage technologies.
- Venture Fund Returns: Returns from affiliated venture funds including Integra (healthcare investment) and Racah Nano Fund (nanotechnology investment) which have first right to examine and invest in Hebrew University innovations.
- Spin-off Equity: Equity participation and value creation through the creation of new companies based on Hebrew University technologies.
Go-to-market motion3 records
Distribution channels5 records
Marketing channels8 records
Yissum Technology Transfer Company of the Hebrew University product offering
Product offeringCore offering
Yissum is the technology transfer company of The Hebrew University of Jerusalem, commercializing academic research through patent licensing, sponsored research agreements, and spin-off company creation. It manages a portfolio of over 10,500 patents and 2,500 inventions across 13 technology categories, offering industry partners access to 1,022 researchers and 222 available technologies for exclusive or non-exclusive licensing. Revenue is generated through licensing royalties, sponsored research fees, equity participation in spin-offs, and returns from affiliated venture funds (Integra and Racah Nano Fund).
Product overview
Yissum is the technology transfer company of The Hebrew University of Jerusalem, founded in 1964 as the world's third tech transfer company. Rather than offering a single unified product, Yissum operates as an IP management and commercialization ecosystem that connects 1022 Hebrew University researchers with industry partners through multiple service channels: Licensing Services, Sponsored Research, Enterprise Directed Research (EDGES), and Spin-off Creation. The ecosystem encompasses 222 available technologies across 12 categories (Pharmaceuticals, AgTech, FoodTech, Diagnostics, Computer Science, Chemistry, Medical Devices, Quantum, and more), 44 lab capabilities, and 112 portfolio companies including notable successes like Mobileye, Doxil, and Exelon. The technology portfolio includes specific offerings such as the AI-Powered Discovery Platform for sweeteners, PheLiz antimicrobial peptide technology, NKp46-Directed ADC Platform, and RNAble Ltd. Beyond technology transfer, Yissum provides educational content through the 'Out of the Lab' podcast and EduCann cannabis course, and offers administrative services including Declaration of Invention (DOI) processing for IP protection.
Differentiator
Problem solved
Functional benefit
Brands
- EduCann: Premiere virtual educational platform for the medical community focused on cannabis research and treatments.
Products and services
- Licensing Services Quick and efficient access to Hebrew University researchers' expertise and cutting-edge technology through granting licenses for patented and copyrighted inventions and know-how. Licenses are granted under varied terms to suit business needs of industry partners.
- Sponsored Research Facilitation of partnership with Hebrew University researchers to advance science and early-stage technologies, reducing cost and time associated with early-stage research for industry partners.
- Enterprise Directed Research (EDGES) Enterprise Directed Research program where industry partners approach with a defined technological problem and parties collaborate to author and distribute RFPs to Hebrew University researchers for collaborative solutions.
- Spin-off Company Creation Formation of new companies from Hebrew University research, with support for entrepreneurs and investors to bring transformative technologies to market. 112 companies currently in portfolio including Mobileye, Doxil, Exelon, OrCam, TriEye, and Future Meat Technologies.
- EduCann Educational Course 13-part educational online course for healthcare professionals about cannabis research and treatments, featuring professors from Hebrew University and Hadassah University Hospital.
- Lab Capabilities Services 44 lab capabilities and services offered through Hebrew University researchers across various scientific disciplines.
- Out of the Lab Podcast Podcast hosted by Molly Livingstone featuring Hebrew University researchers discussing breakthrough science, innovation, passions, and commercialization journeys, with new episodes every two weeks.
- Technology Catalog (222 Available Technologies) Comprehensive catalog of 222 available technologies across 12 categories (AgTech, Pharmaceuticals, FoodTech, Diagnostics, Computer Science, Chemistry, Medical Devices, Quantum, and more), managed by 1,022 researchers.
Quantifiable outcome
- Spinout companies raised $79 million in H1 2020 despite COVID-19 uncertainty
- +3 more outcomes
Companies that use Yissum Technology Transfer Company of the Hebrew University
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles4 records
Yissum Technology Transfer Company of the Hebrew University technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability15 records
Feature4 records
Yissum Technology Transfer Company of the Hebrew University partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core, flagship and minor.
- Clearmind Medicine Inc.coreClearmind Medicine signed research agreement with Yissum Research Development Company of Hebrew University to fund 12-month preclinical study evaluating MEAI (CMND-100) in diet-induced obese mice, both in combination with tirzepatide and as maintenance therapy following tirzepatide treatment. Study conducted by Professor Joseph Tam's team.
- Harvard University (Kempner Institute)flagshipCollaboration between Kempner Institute at Harvard and Edmond and Lily Safra Center for Brain Sciences (ELSC) at Hebrew University to advance NeuroAI, bringing together leading researchers in neuroscience, machine learning, cognitive science, and artificial intelligence.
- GamgeeminorAmsterdam-based smart home company partnered with Yissum for development of machine learning algorithms enabling seamless identification across multi-vendor smart home and IoT devices.
- NetZero Tech VenturescoreStrategic partnership working closely with Yissum to bridge world-class research with real-world climate and energy applications. Yissum serves as catalyst for innovation driving meaningful solutions from lab to market.
- Fresh-Start FoodTech IncubatorcorePartnership that has built six companies together. Fresh-Start values Yissum's scientific strength, strategic mindset, and genuine collaboration that consistently turns breakthrough research into strong, investable ventures.
- ICLcoreLong-standing collaboration with Hebrew University. ICL values Yissum's scientific excellence, professionalism, and practical approach that make joint work focused, efficient, and impactful with creative insights delivering real value.
- Merck Healthcare R&D Center IsraelcoreContinuing collaboration with Yissum and Hebrew University. Merck Healthcare values cooperative mindset, scientific rigor, and professionalism ensuring targeted and effective joint initiatives. Yissum instrumental in establishing connections with Principal Investigators.
- IBM ResearchcoreInnovation Corner collaboration featuring Dr. Aya Soffer, VP AI Technologies at IBM Research, for discussions on the reality behind AI. Yissum hosts meetups bringing together industry leaders with Hebrew University researchers.
- PfizercoreInnovation Corner collaboration on AI in Pharma: From Hype to Real Value. Yissum facilitates discussions between Pfizer and Hebrew University researchers on practical applications of AI in pharmaceutical development.
- CCFI (Chambre de Commerce France Israel)minorFirst webinar collaboration with CCFI (France-Israel Chamber of Commerce) aimed at fostering partnerships with French companies, investors, and entrepreneurs. Engaged around 20 French company representatives.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
Yissum Technology Transfer Company of the Hebrew University competitors and assessment
Company assessmentRegional players
- Integra Holdings: Hebrew University-affiliated healthcare investment company with first-look rights on HUJI biotech IP. Operates as Yissum's specialized healthcare investment vehicle; closely intertwined as ecosystem participant.
Direct peers
- Cambridge Enterprise: The University of Cambridge's technology transfer office, responsible for licensing Cambridge IP and supporting spin-outs. A direct peer in academic IP commercialization with similar deal flow and licensing economics.
- MIT Technology Licensing Office: MIT's central office for managing inventions, patents, and licensing from MIT research. A direct peer in academic IP commercialization with comparable scale and global pharma/tech licensing activity.
- Ramot (Tel Aviv University): Technology transfer company of Tel Aviv University, managing TAU IP, licensing, and spin-offs. Directly comparable as a fellow Israeli university TTO competing in the same domestic ecosystem.
- Oxford University Innovation: The technology transfer company of the University of Oxford, handling Oxford's IP, licensing, and spin-out creation. Closely mirrors Yissum's structure as a university-affiliated for-profit TTO.
- Stanford Office of Technology Licensing: Stanford University's TLO responsible for managing Stanford IP, licensing inventions, and supporting startup formation. Operates the same university-exclusive tech transfer model as Yissum.
- Columbia Technology Ventures: Technology transfer office for Columbia University managing patents, licensing, and spin-offs from Columbia research. Directly comparable as a US university-affiliated TTO with a similar IP commercialization model.
- Technion Technology Transfer (T3): The Technion's technology transfer arm managing IP, licensing, and startup creation from Technion research. A direct Israeli peer with overlapping sectors in computer science, biotech, and engineering.
- BGN Technologies: Technology transfer company of Ben-Gurion University of the Negev, managing BGU IP and spin-offs. A regional peer in Israel offering overlapping capabilities in water, agriculture, and clean-tech licensing.
Broad incumbents
- Clarivate (IP Group): Global IP analytics and patent services provider serving life sciences and tech industries. Adjacent incumbent offering the IP intelligence, search, and patent analytics tooling that academic TTOs rely on.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Yissum Technology Transfer Company of the Hebrew University social profiles
Digital presenceYissum Technology Transfer Company of the Hebrew University financial estimates
Financial estimateRevenue estimate
Valuation estimate
Yissum Technology Transfer Company of the Hebrew University leadership team
Management profileNumber of profiles
Profiles23 records
Yissum Technology Transfer Company of the Hebrew University funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Yissum Technology Transfer Company of the Hebrew University M&A and investment
M&A and investmentM&A
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Yissum Technology Transfer Company of the Hebrew University
What does Yissum Technology Transfer Company of the Hebrew University do?
Yissum is the technology transfer company of The Hebrew University of Jerusalem, commercializing academic research through patent licensing, sponsored research agreements, and spin-off company creation. It manages a portfolio of over 10,500 patents and 2,500 inventions across 13 technology categories, offering industry partners access to 1,022 researchers and 222 available technologies for exclusive or non-exclusive licensing. Revenue is generated through licensing royalties, sponsored research fees, equity participation in spin-offs, and returns from affiliated venture funds (Integra and Racah Nano Fund).
Is Yissum Technology Transfer Company of the Hebrew University a public or private company?
Yissum Technology Transfer Company of the Hebrew University is a private company. It is classified as unknown and is currently operating.
When was Yissum Technology Transfer Company of the Hebrew University founded?
Yissum Technology Transfer Company of the Hebrew University was founded in 1964. It employs 11 to 50 people.
Where is Yissum Technology Transfer Company of the Hebrew University based?
Yissum Technology Transfer Company of the Hebrew University is headquartered in Jerusalem, Israel, in the Middle East region.
How does Yissum Technology Transfer Company of the Hebrew University make money?
Four revenue lines are on record. Licensing Royalties are the primary driver. The others are sponsored Research Agreements, venture Fund Returns and spin-off Equity.
Who are Yissum Technology Transfer Company of the Hebrew University's main competitors?
Integra Holdings is listed as a regional player. Direct peers are Cambridge Enterprise, MIT Technology Licensing Office, Ramot (Tel Aviv University), Oxford University Innovation, Stanford Office of Technology Licensing, Columbia Technology Ventures, Technion Technology Transfer (T3) and BGN Technologies. Clarivate (IP Group) is listed as a broad incumbent.
Does Yissum Technology Transfer Company of the Hebrew University have an API?
No public API is recorded for Yissum Technology Transfer Company of the Hebrew University.
What industry is Yissum Technology Transfer Company of the Hebrew University in?
Yissum Technology Transfer Company of the Hebrew University's product category is Technology Transfer & Intellectual Property Commercialization. Its primary akta.pro industry code is BPAHAMAF, IP Licensing, Transactions & Technology Transfer, with a secondary code of EDAHABAH, Technology Transfer & Innovation-Driven Research Universities (High Commercialization). Its NAICS code is 533 and its SIC code is 6794.